[Federal Register Volume 80, Number 239 (Monday, December 14, 2015)]
[Notices]
[Page 77352]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-31367]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control, (BSC, NCIPC)

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces, the following meeting of the aforementioned 
committee:
    Time and Date: 9:00 a.m.-1:00 p.m., January 7, 2016 (OPEN).
    Place: Teleconference Dial-In Number: 1-888-395-7561, Participant 
Code: 3954121.
    Status: The meeting as designated above will be open to the public.
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury.
    The Board of Scientific Counselors makes recommendations regarding 
policies, strategies, objectives, and priorities; and reviews progress 
toward injury prevention goals and provides evidence in injury 
prevention-related research and programs. The Board also provides 
advice on the appropriate balance of intramural and extramural 
research, the structure, progress and performance of intramural 
programs. The Board is designed to provide guidance on extramural 
scientific program matters, including the: (1) Review of extramural 
research concepts for funding opportunity announcements; (2) conduct of 
Secondary Peer Review of extramural research grants, cooperative 
agreements, and contracts applications received in response to the 
funding opportunity announcements as it relates to the Center's 
programmatic balance and mission; (3) submission of secondary review 
recommendations to the Center Director of applications to be considered 
for funding support; (4) review of research portfolios, and (5) review 
of program proposals.
    Matters for Discussion: The Board of Scientific Counselors will 
discuss the background for development of the CDC Guideline for 
Prescribing Opioids for Chronic Pain (Guideline) and the formation of 
the Prescribing Opioids for Chronic Pain Workgroup (Opioid Guideline 
Workgroup). We will be accepting public comments only related to the 
formation of the Opioid Guideline Workgroup. There will be 30 minutes 
allotted for public comments at the end of the session. All public 
comments will be limited to two-minutes per speaker.
    CDC is also publishing a related notice in today's Federal Register 
announcing the opening of a public comment period on the Guideline 
itself. Individuals are given 30 days to provide comments on the 
Guideline. Please see instructions in that notice about providing 
comment.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Arlene Greenspan, Dr. P.H, 
M.P.H., P.T., Associate Director for Science, NCIPC, CDC, 4770 Buford 
Highway NE., Mailstop F-63, Atlanta, Georgia 30341, Telephone (770) 
488-4696.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-31367 Filed 12-11-15; 8:45 am]
 BILLING CODE 4163-18-P